These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1690 related articles for article (PubMed ID: 17517187)

  • 21. In vivo perfusion of human skin substitutes with microvessels formed by adult circulating endothelial progenitor cells.
    Kung EF; Wang F; Schechner JS
    Dermatol Surg; 2008 Feb; 34(2):137-46. PubMed ID: 18190540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biocompatibility and recellularization potential of an acellular porcine heart valve matrix.
    Wilcox HE; Korossis SA; Booth C; Watterson KG; Kearney JN; Fisher J; Ingham E
    J Heart Valve Dis; 2005 Mar; 14(2):228-36; discussion 236-7. PubMed ID: 15792184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction of tissue-engineered homograft bioprosthetic heart valves in vitro.
    Bin F; Yinglong L; Nin X; Kai F; Laifeng S; Xiaodong Z
    ASAIO J; 2006; 52(3):303-9. PubMed ID: 16760720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineering of vascular grafts with genetically modified bone marrow mesenchymal stem cells on poly (propylene carbonate) graft.
    Zhang J; Qi H; Wang H; Hu P; Ou L; Guo S; Li J; Che Y; Yu Y; Kong D
    Artif Organs; 2006 Dec; 30(12):898-905. PubMed ID: 17181830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promotion of adhesion and proliferation of endothelial progenitor cells on decellularized valves by covalent incorporation of RGD peptide and VEGF.
    Zhou J; Ding J; Nie B; Hu S; Zhu Z; Chen J; Xu J; Shi J; Dong N
    J Mater Sci Mater Med; 2016 Sep; 27(9):142. PubMed ID: 27541486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells.
    Hoerstrup SP; Kadner A; Melnitchouk S; Trojan A; Eid K; Tracy J; Sodian R; Visjager JF; Kolb SA; Grunenfelder J; Zund G; Turina MI
    Circulation; 2002 Sep; 106(12 Suppl 1):I143-50. PubMed ID: 12354724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical application of tissue engineered human heart valves using autologous progenitor cells.
    Cebotari S; Lichtenberg A; Tudorache I; Hilfiker A; Mertsching H; Leyh R; Breymann T; Kallenbach K; Maniuc L; Batrinac A; Repin O; Maliga O; Ciubotaru A; Haverich A
    Circulation; 2006 Jul; 114(1 Suppl):I132-7. PubMed ID: 16820562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning.
    Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S
    Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves.
    Kasimir MT; Rieder E; Seebacher G; Nigisch A; Dekan B; Wolner E; Weigel G; Simon P
    J Heart Valve Dis; 2006 Mar; 15(2):278-86; discussion 286. PubMed ID: 16607912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of cholecyst-derived extracellular matrix on the phenotypic behaviour of valvular endothelial and valvular interstitial cells.
    Brody S; McMahon J; Yao L; O'Brien M; Dockery P; Pandit A
    Biomaterials; 2007 Mar; 28(8):1461-9. PubMed ID: 17174391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth.
    Weber B; Zeisberger SM; Hoerstrup SP
    Placenta; 2011 Oct; 32 Suppl 4():S316-9. PubMed ID: 21575988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reendothelialization of tubular scaffolds by sedimentary and rotative forces: a first step toward tissue-engineered venous graft.
    Wu YF; Zhang J; Gu YQ; Li JX; Wang LC; Wang ZG
    Cardiovasc Revasc Med; 2008; 9(4):238-47. PubMed ID: 18928949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of autologous human heart valves based on an acellular allograft matrix.
    Cebotari S; Mertsching H; Kallenbach K; Kostin S; Repin O; Batrinac A; Kleczka C; Ciubotaru A; Haverich A
    Circulation; 2002 Sep; 106(12 Suppl 1):I63-I68. PubMed ID: 12354711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential cell sources for tissue engineering of heart valves in comparison with human pulmonary valve cells.
    Schaefermeier PK; Cabeza N; Besser JC; Lohse P; Daebritz SH; Schmitz C; Reichart B; Sodian R
    ASAIO J; 2009; 55(1):86-92. PubMed ID: 19092668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human endothelial cell growth and phenotypic expression on three dimensional poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering.
    Jabbarzadeh E; Jiang T; Deng M; Nair LS; Khan YM; Laurencin CT
    Biotechnol Bioeng; 2007 Dec; 98(5):1094-102. PubMed ID: 17497742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human umbilical cord cells for cardiovascular tissue engineering: a comparative study.
    Kadner A; Zund G; Maurus C; Breymann C; Yakarisik S; Kadner G; Turina M; Hoerstrup SP
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):635-41. PubMed ID: 15037283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional stability of endothelial cells on a novel hybrid scaffold for vascular tissue engineering.
    Pankajakshan D; Krishnan V K; Krishnan LK
    Biofabrication; 2010 Dec; 2(4):041001. PubMed ID: 21076184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of porcine circulating progenitor cells: toward a functional endothelium.
    Allen J; Khan S; Serrano MC; Ameer G
    Tissue Eng Part A; 2008 Jan; 14(1):183-94. PubMed ID: 18333816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic engineering with endothelial nitric oxide synthase improves functional properties of endothelial progenitor cells from patients with coronary artery disease: an in vitro study.
    Kaur S; Kumar TR; Uruno A; Sugawara A; Jayakumar K; Kartha CC
    Basic Res Cardiol; 2009 Nov; 104(6):739-49. PubMed ID: 19479297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cryopreserved amniotic fluid-derived cells: a lifelong autologous fetal stem cell source for heart valve tissue engineering.
    Schmidt D; Achermann J; Odermatt B; Genoni M; Zund G; Hoerstrup SP
    J Heart Valve Dis; 2008 Jul; 17(4):446-55; discussion 455. PubMed ID: 18751475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 85.